PharmChem, Inc.
PCHM
$3.40
$0.0270.80%
OTC PK
| 09/30/2003 | 06/30/2003 | 03/31/2003 | 12/31/2002 | 09/30/2002 | |
|---|---|---|---|---|---|
| Revenue | 6.94M | 7.11M | 6.34M | 7.23M | 7.32M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 6.94M | 7.11M | 6.34M | 7.23M | 7.32M |
| Cost of Revenue | 5.28M | 5.55M | 5.13M | 5.31M | 5.79M |
| Gross Profit | 1.66M | 1.57M | 1.21M | 1.92M | 1.53M |
| SG&A Expenses | 1.98M | 1.98M | 1.80M | 1.72M | 2.19M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.26M | 7.53M | 6.92M | 7.02M | 7.98M |
| Operating Income | -320.00K | -415.00K | -588.00K | 205.00K | -667.00K |
| Income Before Tax | 249.00K | -555.00K | -733.00K | 49.00K | -825.00K |
| Income Tax Expenses | -- | -- | -- | 0.00 | -- |
| Earnings from Continuing Operations | 249.00K | -555.00K | -733.00K | 49.00K | -825.00K |
| Earnings from Discontinued Operations | -- | -- | -- | 0.00 | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 249.00K | -555.00K | -733.00K | 49.00K | -825.00K |
| EBIT | -320.00K | -415.00K | -588.00K | 205.00K | -667.00K |
| EBITDA | 165.00K | 116.00K | -28.00K | 758.00K | -90.00K |
| EPS Basic | 0.04 | -0.09 | -0.13 | 0.01 | -0.14 |
| Normalized Basic EPS | -0.04 | -0.06 | -0.08 | 0.01 | -0.09 |
| EPS Diluted | 0.04 | -0.09 | -0.13 | 0.01 | -0.14 |
| Normalized Diluted EPS | -0.04 | -0.06 | -0.08 | 0.01 | -0.09 |
| Average Basic Shares Outstanding | 5.85M | 5.85M | 5.85M | 5.85M | 5.85M |
| Average Diluted Shares Outstanding | 5.92M | 5.85M | 5.85M | 5.85M | 5.85M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |